Cataracts in transgenic mice caused by a human papillomavirus type 18 E7 oncogene driven by KRT1-14

Experimental and Molecular Pathology

Volumn 85, Issue 2, 2008, Pages 77-82

  Ghim, Shinje ^a   Jenson, A Bennett ^a   Bubier, Jason A ^b   Silva, Kathleen A ^b   Smith, Richard S ^b   Sundberg, John P ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Animal model; Cataracts; Human papillomavirus; Transgenic mice

Indexed keywords

CYTOKERATIN 14; PROTEIN E7;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACTOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOHISTOCHEMISTRY; LENS EPITHELIUM; LENS NUCLEUS; MALE; MOUSE; NONHUMAN; TRANSGENIC MOUSE; UTERINE CERVIX CANCER; VIRUS ONCOGENE;

ANIMALS; CATARACT; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS (GENETICS); TRANSGENES;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; MUS; MUS MUSCULUS;

EID: 52149100339     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.07.004     Document Type: Article

References (39)

1. Arbeit J.M., et al. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J. Virol. 68 (1994) 4358-4368
2. de Villiers E.M., et al. Classification of papillomaviruses. Virology 324 (2004) 17-27
3. Elamaa H., et al. Endostatin overexpression specifically in the lens and skin leads to cataract and ultrastructural alterations in basement membranes. Am. J. Pathol. 166 (2005) 221-229
4. Frederikse P.H., and Ren X.O. Lens defects and age-related fiber cell degeneration in a mouse model of increased AbetaPP gene dosage in Down syndrome. Am. J. Pathol. 161 (2002) 1985-1990
5. Gotz W., et al. Eye pathology in transgenic mice carrying a MSV-SV 40 large T-construct. Exp. Eye Res. 52 (1991) 41-49
6. Govindarajan V., et al. Intracorneal positioning of the lens in Pax6-GAL4/VP16 transgenic mice. Mol. Vis. 11 (2005) 876-886
7. Graw J., et al. Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1202-1213
8. Griep A.E., et al. Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J. Virol. 67 (1993) 1373-1384
9. Helt A.-M., and Galloway D.A. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24 (2003) 159-169
10. Herber R., et al. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 70 (1996) 1873-1881
11. Hosokawa M., et al. Persistent hyaloid vascular system in age-related cataract in a SAM strain of mouse. Exp. Eye Res. 57 (1993) 427-434
12. Kaufmann A.M., et al. HPV induced cervical carcinogenesis: molecular basis and vaccine development. Zentralbl Gynakol. 124 (2002) 511-524
13. Klopp N., et al. Three murine cataract mutants (Cat2) are defective in different gamma-crystallin genes. Genomics 52 (1998) 152-158
14. Kuck J.F.R. Late onset hereditary cataract of the Emory mouse. A model for human senile cataract. Exp. Eye Res. 50 (1990) 659-664
15. Mahon K.A., et al. Oncogenesis of the lens in transgenic mice. Science 235 (1987) 1622-1628
16. Mikaelian I., et al. Antibodies that label paraffin-embedded mouse tissues: a collaborative endeavor. Toxicol. Pathol. 32 (2004) 1-11
17. Mikaelian I., et al. Expression of terminal differentiation proteins defines stages of mouse mammary gland development. Vet. Pathol. 43 (2006) 36-49
18. Munoz N., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer 111 (2004) 278-285
19. Overbeek P.A., et al. Lens-specific expression and developmental regulation of the bacterial chloramphenicol acetyltransferase gene driven by the murine alpha A crystallin promoter in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 7815-7819
20. Paterson C.A., and Delamere N.A. The lens (1992), Mosby-Yearbook Publishers, St Louis
21. Pichel J.G., et al. Timing of SV40 oncogene activation by site-specific recombination determines subsequent tumor progression during murine lens development. Oncogene 8 (1993) 3333-3342
22. Reddy M.A., et al. Molecular genetic basis of inherited cataract and associated phenotypes. Surv. Ophthalmol. 49 (2004) 300-315
23. Relyea M.J., et al. Immunohistochemical and immunofluorescence methods. In: Sundberg J.P., and Boggess D. (Eds). Systematic approach to evaluation of mouse mutations (2000), CRC Press, Boca Raton, FL 131-144
24. Reneker L.W., and Overbeek P.A. Lens-specific expression of PDGF-A in transgenic mice results in retinal astrocytic hamartomas. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2455-2466
25. Resnikoff S., et al. Global data on visual impairment in the year 2002. Bull. World Health Organ. 82 (2004) 844-851
26. Roden R., and Wu T.C. How will HPV vaccines affect cervical cancer?. Nat. Rev. Cancer 6 (2006) 753-763
27. Santhiya S.T., et al. Reduced levels of gamma-crystallin transcripts during embryonic development of murine Cat2nop mutant lenses. Graefes. Arch. Clin. Exp. Ophthalmol. 233 (1995) 795-800
28. Seymour R., et al. Necropsy methods. In: Hedrich H.J. (Ed). Laboratory mouse (2004), Academic Press, London 495-516
29. Smith R.S. Choroid, lens, and vitreous. In: Smith R.S. (Ed). Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods (2002), CRC Press, Boca Raton, FL 161-194
30. Smith R.S., et al. Mouse mutations as models for studying cataracts. Pathobiology 65 (1997) 146-154
31. Smith R.S., et al. Lens epithelial proliferation cataract in segmental trisomy involving mouse Chromosomes 4 and 17. Mamm. Genome 10 (1999) 102-106
32. Smith R.S., et al. Lop12, a mutation in mouse Crygd causing lens opacity similar to human Coppock cataract. Genomics 63 (2000) 314-320
33. Song S., et al. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J. Virol. 73 (1999) 5887-5893
34. Spencer W.H. Ophthalmic Pathology: An Atlas and Textbook (1996), W B Saunders Company, Philadelphia
35. Sundberg J.P., et al. Myoepitheliomas in inbred laboratory mice. Vet. Pathol. 28 (1991) 313-323
36. Sundberg J.P., et al. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10. Cancer Res. 54 (1994) 1344-1351
37. Sundberg J.P., et al. The nonhuman (animal) papillomaviruses: host range, epitope conservation, and molecular diversity. In: Gross G., and vonKrogh G. (Eds). Human Papillomavirus Infections in Dermatology and Venereology (1996), CRC Press, Inc., Boca Raton 47-68
38. VanAgtmael T., et al. Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Hum. Mol. Genet. 14 (2005) 3161-3168
39. Wise-Draper T.M., and Wells S.I. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci. 13 (2008) 1003-1017